Skip to main content
Podcast microphone headphones
Day 1 (part one): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 1 (part two): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Podcast microphone headphones
Day 4: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 3: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 2 (part two) ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 2 (part one) Podcast
RheumNow
RheumNow Podcast – ACR 2019  Round Up (11.15.19)
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
  • #1223 ALLN-346 a urate degrading enzyme in a pig model of gout
  • #L06 Emapalumab for treating MAS in systemic JIA patients
  • #1890 and 2357 Methotrexate Safety from CIRT
  • #1240 Anakinra in acute gout – anaGO study
  • #2292, #2279 When to withdraw biologics in RA patients who become pregnant
  • #633, #631 Delays in referral of LBP
  • #196 VTE risk and future ASCVD risk
  • #2566 Polypharmacy
  • #860 EMBRACE – Belimumab in Blacks
Podcast microphone headphones
ACR Posters
ACR 2019 - Report from Day 3 (Tuesday)
Jack Cush, MD
Here's my summary of key studies presented Tuesday.  Tofacitinib in Polyarticular JIA
iv infusion hospital drip
Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the immunotherapy has ceased, according to data presented at ACR 2019 in Atlanta, Georgia.
Smile frown emoticon happy sad
Can The Happiest Subspecialists Experience Burnout?
Kanika Monga, MD
The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work. I was not really surprised by reading that, and I would go as far as saying that our
Non-radiographic axSpA: Dr. Philip Robinson

Dr. Robinson highlights a presentation on non-radiographic axial spondyloarthritis presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Panel Presentation: The X Factor

Drs. Rachel Tate, Kathryn Dao, Kanika Monga, Courtney Crayne, and Arundathi Jayatillekey discuss issues, ideas and opportunities around the topic of women in rheumatology, with special guest Dr. Eric Ruderman, at the 2019 ACR/ARP Annual Meeting in Atlanta. 

neon question mark
At the 2019 ACR Annual Meeting in Atlanta, almost 500 presentations discussed new randomized controlled trials (RCTs). We are lucky to have so much research activity in our field, but applying an RCT to your daily practice can be challenging. Here are three tips to supercharge your critical
vasculitis open hand
Hepatitis C-related cryoglobulinemic vasculitis 
David Liew, MD
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.
Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta. 

vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.
needle haystack rare
Autoinflammatory Diseases at the ACR Annual Meeting
Jonathan Hausmann, MD
It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting. I attended my first ACR Annual Meeting in 2011 in Chicago. In that meeting, there were 29 abstracts on autoinflammatory diseases and there were no sessions exclusively focusing on that topic*.
High Dose Influenza Vaccine Under Age 65: Dr. David Liew

Dr. David Liew discusses abstract #2091 The High Dose Influenza Vaccine Increases Immune Protection in Both Adults and Elderly Seropositive RA Patients presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Pearls for Evaluating PSA patients: Dr. Guillermo Valenzuela

Dr. Valenzuela describes a variety of pearls for evaluating PSA patients at the 2019 ACR/ARP annual meeting in Atlanta. 

Vasculitis Pearls: Dr. Kathryn Dao

Dr. Dao shares several vasculitis pearls presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Panel Presentation: Spondyloarthritis

Drs. Jack Cush, Christopher Ritchlin, Sophia Ramiro, Lianne Gensler, and Jessica Walsh discuss interesting new trials and data presented in ankylosing spondylitis and spondyloarthritis at the 2019 ACR/ARP annual meeting in Atlanta.  

Panel Presentation: Gout

Drs. Jack Cush, Nicola Dalbreth, Ken Saag and Robert Keenan discuss several gout presentations, including tart cherry, safety and efficacy of therapies, quality of life issues and more at the 2019 ACR/ARP annual meeting in Atlanta. 

RT @_connectedcare: Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessationAnecdotally, there are people who…

Dr Irwin Lim _connectedcare

7 months 3 weeks ago

Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655

#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention1366 Self Joint exams1120 Rheum burnout1310 OA Hx565 Enteropathic arthritis Re

Dr. John Cush RheumNow

7 months 3 weeks ago

#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx

#ACR19 Rheumatology RoundUp - Cushs Abstract Picks:
1223 ALLN-346 Urate Degrading Enzyme
L06 Emapalumab in MAS
1890 2357 MTX Safety
1240 anaGO
22

Dr. John Cush RheumNow

7 months 3 weeks ago
#ACR19 Rheumatology RoundUp - Cushs Abstract Picks: 1223 ALLN-346 Urate Degrading Enzyme L06 Emapalumab in MAS 1890 2357 MTX Safety 1240 anaGO 2292 2279 Biologic WD in Preg 633 631 AS Delays in Dx & referral 196 VTE & ASCVD 2566 Polypharmacy in SLE
RT @hausmannMD: CAPS is caused by mutations in NLRP3, a component of the inflammasome.

It is thought that NLRP3 mutations lead to the unc…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
CAPS is caused by mutations in NLRP3, a component of the inflammasome. It is thought that NLRP3 mutations lead to the uncontrolled production of the inflammatory cytokine IL-1b.
RT @hausmannMD: Patients with more severe #CAPS phenotypes may develop hearing loss, amyloidosis, aseptic meningitis, intellectual impairme…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
Patients with more severe #CAPS phenotypes may develop hearing loss, amyloidosis, aseptic meningitis, intellectual impairment, or #arthritis.
RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago

Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #ACR19 @RheumNow

RT @hausmannMD: "I usually do not" give methotrexate to men with RA who are trying to conceive. Dr. Bathon.

"But methotrexate is in serum…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
"I usually do not" give methotrexate to men with RA who are trying to conceive. Dr. Bathon. "But methotrexate is in serum for brief periods, unlikely to affect semen, unlikely to affect pregnancy." Dr. Bykerk #ACR19 @RheumNow
RT @hausmannMD: https://t.co/Zdx0syodMK

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
https://t.co/Zdx0syodMK
RT @hausmannMD: Awesome to meet new people from across the globe, catch up with old friends, and discuss why #ACR20 should have abundant fr…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
Awesome to meet new people from across the globe, catch up with old friends, and discuss why #ACR20 should have abundant free food! https://t.co/lEdYZM9BHB
RT @hausmannMD: However, 15-30% of patients with acute pericarditis develop recurrent pericarditis

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
However, 15-30% of patients with acute pericarditis develop recurrent pericarditis
RT @hausmannMD: Recurrent pericarditis (RP) is the recurrence of pericarditis after a more than 4-6 week symptom-free period.

RP is typica…

Jonathan Hausmann MD hausmannMD

7 months 3 weeks ago
Recurrent pericarditis (RP) is the recurrence of pericarditis after a more than 4-6 week symptom-free period. RP is typically treated with steroids, colchicine, NSAIDs. Nevertheless, RP is associated with a high burden of disease and there is an unmet need for better treatment.
×